Entera Bio to Present at Aegis Virtual Conference on February 23rd
BOSTON and JERUSALEM, Israel, Feb. 17, 2022 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), a leader in the development...
Month: February 2022
AREV Life Sciences Advances Developments, New Appointments and Relationships
VANCOUVER, British Columbia , Feb. 17, 2022 (GLOBE NEWSWIRE) -- via InvestorWire – AREV Life Sciences Global Corp. (CSE: AREV)...
Celsion Reports Data Safety Monitoring Board Unanimous Recommendation to Continue Dosing Patients in the Phase II Portion of the OVATION 2 Study with GEN-1 in Advanced Ovarian Cancer
OVATION 2 Study is Over 75% Enrolled; Full Enrollment Expected by Mid-2022 Novel Gene-Mediated Immunotherapy is Safe and Demonstrates an Acceptable Risk/Benefit When Administered Over a Six-Month Period LAWRENCEVILLE, N.J.,...
GIMOTI® Commercialization Update
New Research Study Demonstrates Increased Acceptance Among Healthcare Providers Patient Testimonial Videos Detail Benefits Included and Available on GimotiRx.com Expanded...
Fluidigm Announces Collaboration Agreement with the Abu Dhabi Stem Cells Center to Accelerate Imaging Mass Cytometry in Development of Targeted Stem Cell Therapies
Collaboration Enables Further Expansion of Mass Cytometry in the Middle EastSOUTH SAN FRANCISCO, Calif., Feb. 17, 2022 (GLOBE NEWSWIRE) --...
Catalyst Pharmaceuticals to Launch LEMS Aware Podcast on Rare Disease Day 2022
Initiative Part of Expansion of Education and Awareness Activities for Lambert-Eaton Myasthenic Syndrome CommunityCORAL GABLES, Fla., Feb. 17, 2022 (GLOBE...
Salarius Pharmaceuticals to Present at the Diamond Equity Research Emerging Growth Invitational 2022 Virtual Conference
HOUSTON, Feb. 17, 2022 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX), a clinical-stage biopharmaceutical company developing potential new medicines...
Alimera Sciences to Report Fourth Quarter and Full Year 2021 Financial Results on Thursday, February 24, 2022, and Provide Corporate Update
Conference Call to be held Thursday, February 24, 2022, at 9:00am Eastern TimeATLANTA, Feb. 17, 2022 (GLOBE NEWSWIRE) -- Alimera...
Sight Sciences Launches “Don’t Wait for Too Late” Awareness Campaign for Glaucoma
Educational campaign aims to raise awareness among the optometric community of minimally invasive glaucoma surgery (MIGS) as an earlier surgical...
Arvinas PROTAC® Protein Degrader Bavdegalutamide (ARV-110) Continues to Demonstrate Clinical Benefit in Men with Metastatic Castration-Resistant Prostate Cancer
– Bavdegalutamide treatment demonstrated robust activity in molecularly defined tumors (androgen receptor T878X/H875Y), with a 46% PSA50 rate and durable...
Catalyst Biosciences Engages Perella Weinberg Partners to Assist the Company in Exploring Strategic Alternatives
SOUTH SAN FRANCISCO, Calif., Feb. 17, 2022 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (NASDAQ: CBIO) today announced it has retained...
OPKO Health to Report Fourth Quarter 2021 Financial Results on February 24, 2022
MIAMI, Feb. 17, 2022 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for...
Piezo Motion Announces Expansion of Its Precision Motion Motors with New Partnership
Piezo Motion joins forces with Electroline Sales, Inc. to offer disruptive motion control technology to Electroline Sales, Inc.’s diverse customer...
Pharmazz Inc. Announces Completion of Enrollment of Phase III Clinical Trial Evaluating Sovateltide as a Treatment for Acute Cerebral Ischemic Stroke
Sovateltide is an endothelin B receptor agonist that increases blood flow, shows anti-apoptotic activity, protects neural mitochondria, and produces neurovascular...
Study Demonstrates Importance and Clinical Utility of Daxor’s Blood Volume (BVA-100®) Diagnostic in the Assessment of Heart Failure
Daxor’s BVA-100® Shown to Provide Unique and Actionable Data for Addressing Heart Failure Oak Ridge, TN, Feb. 17, 2022 (GLOBE...
Quoin Pharmaceuticals Signs Exclusive Distribution Agreement with Neopharm for its Lead Asset, QRX003, for Netherton Syndrome
Neopharm Gains Exclusive Rights to Commercialize QRX003 in IsraelSixth Distribution Partnership Established Since Quoin’s NASDAQ Debut in October 2021ASHBURN, Va.,...
Longeveron Adds Seasoned Biotech Executive Todd Girolamo to Its Board of Directors
Girolamo brings legal, finance and M&A experience to cell therapy companyMIAMI, Feb. 17, 2022 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ:...
Science 37®’s Community Provider Network Grows Sixfold, Reaching Nearly 28 Million Patients
Since January 2021, Science 37’s community provider network has added nearly 35,000 physician-providers to enable agile clinical trial execution.RESEARCH TRIANGLE...
iSpecimen Reports Full Year 2021 Financial Results
Record FY 2021 Revenue of $11.1 Million, Surpassing FY 2020 Revenue of $8.2 Million by 36%LEXINGTON, Mass., Feb. 17, 2022...
Intellia Therapeutics Announces Two Upcoming Investor Events in February 2022
Fourth quarter and full-year 2021 financial results – February 24, at 8:00 a.m. ETUpdated interim clinical data from the ongoing...
